Nancy E. Dempze’s Biogen BIIB Stock Holding History

Nancy E. Dempze’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,100	Closed	-$312K	–	66
2020 Q3	$312K	Hold	1,100	–	–	0.32%	54
2020 Q2	$294K	Hold	1,100	–	–	0.33%	53
2020 Q1	$348K	Hold	1,100	–	–	0.47%	45
2019 Q4	$326K	Hold	1,100	–	–	0.36%	53
2019 Q3	$256K	Hold	1,100	–	–	0.31%	57
2019 Q2	$257K	Hold	1,100	–	–	0.29%	55
2019 Q1	$260K	Hold	1,100	–	–	0.31%	57
2018 Q4	$331K	Hold	1,100	–	–	0.46%	46
2018 Q3	$389K	Sell	1,100 -100	-8%	-$34.4K	0.44%	50
2018 Q2	$348K	Hold	1,200	–	–	0.43%	54
2018 Q1	$329K	Hold	1,200	–	–	0.41%	57
2017 Q4	$382K	Hold	1,200	–	–	0.46%	56
2017 Q3	$376K	Hold	1,200	–	–	0.53%	52
2017 Q2	$326K	Hold	1,200	–	–	0.47%	60
2017 Q1	$328K	Hold	1,200	–	–	0.5%	60
2016 Q4	$340K	Hold	1,200	–	–	0.6%	54
2016 Q3	$376K	Hold	1,200	–	–	0.66%	47
2016 Q2	$290K	Hold	1,200	–	–	0.52%	64
2016 Q1	$312K	Hold	1,200	–	–	0.55%	59
2015 Q4	$368K	Buy	+1,200	New	+$345K	0.71%	50

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nancy E. Dempze's BIIB Position: Q4 2020 in Review

Nancy E. Dempze sold out of Biogen (BIIB) in Q4 2020, closing a stake of 1,100 shares — an estimated $312K sold.

Nancy E. Dempze first reported a position in BIIB in Q4 2015 and held it in 20 quarters. The position peaked at $389K in Q3 2018. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

Nancy E. Dempze reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
Nancy E. Dempze sold 1,100 Biogen shares in Q4 2020, an estimated $312K.
Nancy E. Dempze first reported a position in Biogen in Q4 2015 and held it in 20 quarters.
Nancy E. Dempze's Biogen position peaked at $389K in Q3 2018.
1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Nancy E. Dempze's 13F filing for Q4 2020, filed 16 Feb 2021.